Toth Financial Advisory’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,001
Closed -$3.2K 751
2024
Q4
$3.2K Hold
1,001
﹤0.01% 542
2024
Q3
$2.86K Hold
1,001
﹤0.01% 559
2024
Q2
$2.8K Hold
1,001
﹤0.01% 576
2024
Q1
$2.84K Hold
1,001
﹤0.01% 573
2023
Q4
$4.09K Buy
+1,001
New +$2.8K ﹤0.01% 552

Other funds holding ORGO

Toth Financial Advisory's ORGO Position: Q1 2025 in Review

Toth Financial Advisory sold out of Organogenesis Holdings (ORGO) in Q1 2025, closing a stake of 1,001 shares — an estimated $3.2K sold.

Toth Financial Advisory first reported a position in ORGO in Q4 2023 and held it in 5 quarters. The position peaked at $4.09K in Q4 2023. 136 funds tracked by Wall St. Rank hold ORGO as of Q1 2025.

  • Toth Financial Advisory reported no remaining Organogenesis Holdings position as of Q1 2025 after selling out during the quarter.
  • Toth Financial Advisory sold 1,001 Organogenesis Holdings shares in Q1 2025, an estimated $3.2K.
  • Toth Financial Advisory first reported a position in Organogenesis Holdings in Q4 2023 and held it in 5 quarters.
  • Toth Financial Advisory's Organogenesis Holdings position peaked at $4.09K in Q4 2023.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2025.

Based on Toth Financial Advisory's 13F filing for Q1 2025, filed 14 Apr 2025.